CA2286279A1 - Diagnosis of neuro-degenerative disorders - Google Patents

Diagnosis of neuro-degenerative disorders Download PDF

Info

Publication number
CA2286279A1
CA2286279A1 CA002286279A CA2286279A CA2286279A1 CA 2286279 A1 CA2286279 A1 CA 2286279A1 CA 002286279 A CA002286279 A CA 002286279A CA 2286279 A CA2286279 A CA 2286279A CA 2286279 A1 CA2286279 A1 CA 2286279A1
Authority
CA
Canada
Prior art keywords
neuro
diagnosis
degenerative disorders
sample
particulate material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002286279A
Other languages
French (fr)
Other versions
CA2286279C (en
Inventor
Harash Kumar Narang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotec Global Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2286279A1 publication Critical patent/CA2286279A1/en
Application granted granted Critical
Publication of CA2286279C publication Critical patent/CA2286279C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic

Abstract

The diagnostic method comprises concentrating a protein associated with the neuro-degenerative disorder in a sample of a body fluid taken from the animal. The concentration is carried out by contacting the sample with a solid, non-buoyant particulate material having free ionic valencies. The resulting protein associated with the neuro-degenerative disorder concentrated on the particulate material is then monitored.
CA002286279A 1998-02-06 1998-02-06 Diagnosis of neuro-degenerative disorders Expired - Fee Related CA2286279C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/GB1998/000374 WO1999040439A1 (en) 1998-02-06 1998-02-06 Diagnosis of neuro-degenerative disorders

Publications (2)

Publication Number Publication Date
CA2286279A1 true CA2286279A1 (en) 1999-08-12
CA2286279C CA2286279C (en) 2009-05-12

Family

ID=10825005

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002286279A Expired - Fee Related CA2286279C (en) 1998-02-06 1998-02-06 Diagnosis of neuro-degenerative disorders

Country Status (4)

Country Link
JP (1) JP2001520755A (en)
AU (1) AU755535B2 (en)
CA (1) CA2286279C (en)
WO (1) WO1999040439A1 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234814A (en) * 1989-06-01 1993-08-10 Du Pont Merck Pharmaceutical Company Diagnostic assay for alzheimer's disease
JPH0327349A (en) * 1989-06-24 1991-02-05 Asahi Optical Co Ltd Separation of protein, peptide and amino acid
WO1993003369A1 (en) * 1991-08-01 1993-02-18 Voorheis Paul H Diagnostic method for alzheimer's disease
GB9117910D0 (en) * 1991-08-20 1991-10-09 Nat Res Dev Oligonucleotides and their use in an assay
SK67797A3 (en) * 1994-11-29 2000-02-14 Mini Agriculture & Fisheries Spongiform encephalopathy detection methods
CA2205179A1 (en) * 1994-11-29 1996-06-06 The Minister Of Agriculture, Fisheries And Food In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Spongiform encephalopathy detection methods
GB9701045D0 (en) * 1997-01-18 1997-03-05 Narang Harash K Diagnosis of neuro-degenerative disorders

Also Published As

Publication number Publication date
CA2286279C (en) 2009-05-12
JP2001520755A (en) 2001-10-30
AU5997698A (en) 1999-08-23
AU755535B2 (en) 2002-12-12
WO1999040439A1 (en) 1999-08-12

Similar Documents

Publication Publication Date Title
ATE180261T1 (en) PROTEINS PRODUCED BY HUMAN LYMPHOCYTES, THE DNA CODING FOR THESE PROTEINS, AND PHARMACEUTICAL AND BIOLOGICAL USES
EP0796865A3 (en) Adsorbent and method for removing chemokines
WO1996009386A3 (en) Allelic variation of the serotonin 5ht2c receptor
FR2570979B1 (en) APPARATUS AND METHOD FOR MOLDING PARTS BY COMPRESSION, PARTICULARLY FOR THE MANUFACTURE OF AUTOMOTIVE BODY ELEMENTS.
IT8567140A1 (en) Improved process for the production of proteins, particularly antibodies, with the use of hypertonic means, and hypertonic medium for carrying out this process.
BE896849A (en) PROCESS FOR ISOMERIZING THE OLEFINIC LINK.
EP0299741A3 (en) Protein or peptide sequencing method and apparatus
GB9701045D0 (en) Diagnosis of neuro-degenerative disorders
DE69016801D1 (en) Directly driven servo valve, pressure medium servo device and control method for the directly driven servo valve.
CA2193318A1 (en) Mass-sensitive biosensors
DE3764357D1 (en) DEVICE FOR CORRECTING THE DRIVE ANGLE OF A MOTOR VEHICLE.
CA2286279A1 (en) Diagnosis of neuro-degenerative disorders
IE44824L (en) Isolation of a placenta-specific glycoprotein.
FR2591339B1 (en) METHOD FOR MEASURING INTERACTION IN THE WALL-FLUID AREA, ESPECIALLY BLOOD FLOW IN VESSELS
EP0112299A3 (en) Method for superoxidic-dismutasis purification via chromatography by affinity
ID21206A (en) THE PROCESS OF PRODUCING SITRATE ACID AND OR SITRATE
CA2199403A1 (en) Novel PKA-Binding Proteins and Uses Thereof
CA2102115A1 (en) In vitro methods for determining in vivo thrombotic events
DE3676029D1 (en) DEVICE FOR REMOVING THE MILKING VEHICLE, IN PARTICULAR FOR COOLERS.
CA2199843A1 (en) Novel PKA-Binding Proteins and Uses Thereof
BR9816079A (en) Diagnosis of neurodegenerative disorders
IT8948449A0 (en) SYSTEM TO AVOID THE WRONG OPERATION OF THE PEDALS WHILE DRIVING A MOTOR VEHICLE EQUIPPED WITH A MANUAL GEARBOX, AND MEANS FOR ITS IMPLEMENTATION.
EP2356994A3 (en) Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
FR2692046B1 (en) PROCESS FOR THE PREPARATION OF A FLUID SAMPLE ON A POROUS SUPPORT FOR ANALYSIS, ESPECIALLY SPECTRO-PHOTOMETRIC.
RU95116196A (en) METHOD FOR DRYING BIOLOGICAL RAW MATERIALS

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed